Afluria Cost In 2026: Pricing Breakdown, Insurance Coverage, And Savings Strategies

Afluria is an inactivated influenza vaccine manufactured by CSL Seqirus, approved by the U.S. Food and Drug Administration (FDA) for individuals six months of age and older. Without health insurance, the retail cash price for a single dose of Afluria ranges between $35 and $55 at major commercial pharmacies, though administrative fees can push total clinical visit costs up to $85.

For the vast majority of insured individuals, the out-of-pocket cost for Afluria remains $0 under mandated preventive care provisions. Understanding how pharmacy billing, administrative codes, and coverage tiers interact ensures patients and healthcare administrators navigate influenza immunization costs effectively throughout the 2026 vaccination season.

Retail Cash Pricing for Afluria Across Major Providers

When purchasing Afluria without insurance, pricing varies depending on the retail pharmacy chain, the specific formulation, and whether the provider bundles clinical administration into the retail sticker price.

Pharmacies typically dispense Afluria via single-dose pre-filled syringes (0.5 mL for patients aged three years and older, and 0.25 mL or 0.5 mL depending on pediatric protocols) or multi-dose vials (5.0 mL). Additionally, Afluria can be administered via the PharmaJet Stratis Needle-Free Injection System for adults aged 18 through 64, which may incur variable administrative line items.

The following pricing data reflects real-world cash pay estimates across national pharmacies, retail clinics, and community healthcare systems in 2026.

Wholesale Acquisition Cost (WAC) vs. Retail Markup

Physicians and outpatient facilities acquire Afluria directly through medical distributors or group purchasing organizations (GPOs). The Wholesale Acquisition Cost (WAC) for Afluria hovers around $20.00 to $24.00 per single-dose syringe pack.

Retail pharmacies apply markups to account for cold-chain storage logistics, biohazard disposal, clinical personnel overhead, and third-party reimbursement risks. Patients seeking the lowest uninsured cash rate routinely find the most competitive pricing at wholesale clubs and discount pharmacy networks, which frequently price core preventive vaccines near wholesale acquisition rates.

Insurance Coverage Frameworks and Out-of-Pocket Rules

Under modern health insurance regulations, patient out-of-pocket expenses for influenza vaccines like Afluria are heavily shielded, provided network guidelines are strictly observed.

Commercial and Employer-Sponsored Insurance

Under Section 2713 of the Affordable Care Act (ACA), non-grandfathered private health plans must provide first-dollar coverage for vaccines recommended by the Advisory Committee on Immunization Practices (ACIP). Because Afluria holds routine seasonal ACIP recommendations:

• In-Network Coverage: Commercial plans cover Afluria at 100% with no copayment, no coinsurance, and no deductible requirement.
• Out-of-Network Penalties: Receiving Afluria from an out-of-network provider or pharmacy exposes the patient to full retail acquisition charges and local administration fees, often requiring manual claim submission for partial balance billing reimbursement.

Medicare Part B vs. Part D Allocations

A widespread area of billing confusion involves which Medicare part covers annual influenza protection:

• Medicare Part B: Covers the seasonal influenza vaccination completely. Afluria is billed under Part B, not Part D prescription drug plans. Beneficiaries owe $0 out-of-pocket, and the annual Part B deductible does not apply.
• Medicare Advantage (Part C): Medicare Advantage plans are legally bound to offer at least the same preventive baseline as Original Medicare. In-network providers cannot assess a copay for Afluria administration to Medicare Advantage enrollees.

Medicaid Coverage

Medicaid coverage for adult immunizations is governed by federal parity requirements under the Inflation Reduction Act provisions, requiring state Medicaid programs to cover ACIP-recommended adult vaccines without cost-sharing. Eligible adult beneficiaries receive Afluria at zero cost across all state-administered Medicaid programs and contracted managed care organizations (MCOs).

Medical Coding and Clinical Administration Billing

Accurate billing ensures clinics receive appropriate reimbursement while preventing unexpected balance billing for patients. Vaccine billing requires two distinct medical codes: one for the vaccine product itself and one for the clinical act of administration.

Clinical Documentation Requirement Medical records must explicitly document the vaccine trade name (Afluria), manufacturer (CSL Seqirus), lot number, expiration date, anatomical injection site, and whether administration was completed via traditional intramuscular needle or the PharmaJet Stratis needle-free system.

Core Medical Billing Codes for Afluria

• CPT 90686: Severe Acute Respiratory Syndrome / Influenza virus vaccine, quadrivalent/trivalent, split virus, preservative free, 0.5 mL dosage, for intramuscular use (Standard single-dose pre-filled syringe for patients 3 years of age and older).
• CPT 90688: Influenza virus vaccine, split virus, with preservative, 0.5 mL dosage (Multi-dose vial formulations).
• CPT 90687: Pediatric formulation, split virus, preservative free, 0.25 mL dosage (For pediatric administration under 3 years old, where clinically indicated).
• CPT 90471: Immunization administration (percutaneous, intradermal, subcutaneous, or intramuscular injections); one vaccine (single or combination vaccine/toxoid).
• HCPCS G0008: Administration of influenza virus vaccine (Specific billing code required for Original Medicare Part B claims).

When physicians utilize the PharmaJet Stratis needle-free jet injection device for eligible adults (18 to 64 years old), documentation must align with regional Medicare Administrative Contractor (MAC) guidelines regarding needleless subcutaneous/intramuscular jet injector administration (CPT 90473), ensuring claims process cleanly without systematic payer rejection.

Program Options for Uninsured and High-Deductible Patients

Uninsured individuals or families enrolled in non-compliant healthcare sharing ministries do not have to pay full commercial retail prices for Afluria. Several structured programs alleviate costs.

1. Vaccines for Children (VFC) Program: A federally funded program that provides vaccines at no cost to children 18 years of age and younger who are uninsured, underinsured, Medicaid-eligible, or American Indian/Alaska Native. Participating private providers and public clinics administer VFC Afluria doses; parents may only be charged a capped regional administrative fee, which must be waived if the family cannot afford it.
2. Federally Qualified Health Centers (FQHCs): Community clinics receiving Section 330 grants from the Health Resources and Services Administration (HRSA) provide preventive immunizations on a sliding fee schedule tied directly to family income relative to the Federal Poverty Guidelines.
3. Local Public Health Departments: County and municipal health agencies receive state immunization allocations each autumn, often staging seasonal drive-through or walk-in clinics offering Afluria at zero cost or for a nominal administrative donation ($10 to $20).
4. Prescription Discount Platforms: For patients utilizing retail pharmacy counters, digital coupon platforms (such as GoodRx, SingleCare, and RxSaver) periodically establish negotiated cash rates for Afluria, generally stabilizing retail syringe prices between $28 and $38.

Afluria vs. Alternative Influenza Vaccines: Comparative Costs

Selecting an influenza vaccine often involves clinical appropriateness weighed against formulary inclusion and acquisition price points. Afluria occupies the standard-dose category alongside competitors like Fluzone and Fluarix.

Clinical Suitability Considerations

Standard-dose Afluria is not preferentially recommended for individuals aged 65 and older if an enhanced vaccine (Fluzone High-Dose, Fluad, or Flublok) is available. While Medicare Part B fully covers both standard Afluria and higher-cost adjuvanted or high-dose vaccines at $0 cost to the senior, clinicians typically reserve Afluria for populations aged 6 months through 64 years due to ACIP clinical preference guidelines.

How to Avoid Unintended Flu Shot Expenses

Surprise bills associated with routine vaccinations stem almost universally from procedural and site-of-service discrepancies rather than the cost of the vaccine serum itself.

• Avoid Standalone Office Visit Encounters: Scheduling an independent physician appointment solely to receive Afluria frequently triggers a separate Evaluation and Management (E/M) office visit fee (e.g., CPT 99212 or 99213). This visit code can be applied to high-deductible plans, resulting in a balance of $100 or more. Instead, receive the vaccine during an annual wellness exam or directly at a contracted retail pharmacy counter.
• Verify Network Pharmacy Participation: Many insurance carriers distinguish between medical benefit networks and pharmacy benefit networks. Confirm that your retail pharmacy of choice is contracted under your prescription drug plan for vaccine administration.
• Confirm Needle-Free Administration Coverage: If opting for Afluria administration via the needle-free PharmaJet system, ask the provider whether the jet-injection administrative fee is fully covered under the standard preventative billing agreement or if an equipment surcharge applies.

Frequently Asked Questions

How much does Afluria cost without insurance?

Without insurance, Afluria costs between $35 and $55 for the vaccine alone at retail pharmacies. If administered in a private medical clinic, standard vaccine administration fees (CPT 90471) can add $25 to $50 to the final bill, raising the total out-of-pocket price to $60 to $105.

Is Afluria completely free with health insurance?

Yes, Afluria is 100% covered with $0 copayment or coinsurance under nearly all commercial health insurance plans, Medicare Part B, and Medicaid. To ensure zero out-of-pocket costs, patients must receive the vaccine from an in-network provider, clinic, or pharmacy counter.

Does Medicare Part B cover the Afluria flu vaccine?

Yes, Original Medicare Part B covers 100% of the cost for Afluria with no deductible or copayment required. Providers bill Afluria using CPT 90686 or 90688 alongside administrative code G0008, which processes directly through the Part B medical benefit rather than Part D prescription drug plans.

Can adults aged 65 and older receive Afluria?

While Afluria is FDA-approved for individuals six months of age and older, the CDC and ACIP preferentially recommend higher-antigen or adjuvanted vaccines (such as Fluzone High-Dose, Fluad, or Flublok) for adults aged 65 and older. If those preferred vaccines are unavailable, standard-dose Afluria can be administered safely.

Is the PharmaJet needle-free Afluria shot more expensive?

The vaccine product itself costs the same, but clinics administering Afluria via the PharmaJet Stratis system may bill a specific jet injection administration code or charge a modest specialized device fee if their third-party payer contract does not bundle needle-free technology under standard preventive administration rates.

Securing Cost-Effective Immunization

Maximizing the value of preventive healthcare requires matching clinical indications with optimal care settings. If you have commercial health insurance, Medicare, or Medicaid, schedule your Afluria vaccination at an in-network retail pharmacy or during your annual preventive physical to eliminate out-of-pocket expense.

For uninsured individuals, consider retail warehouse pharmacies, community health centers, or county health department walk-in clinics to secure the lowest cash price or sliding-scale assistance for your annual immunization needs.